BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Metiscan, Inc. Announces FINRA Approval of Name Change and Reverse Stock Split


1/4/2012 8:53:53 AM

DALLAS, TX--(Marketwire - January 03, 2012) - Metiscan, Inc. (PINKSHEETS: MTIZ) is pleased to announce that FINRA has approved its name change from Metiscan, Inc. to Aclor International, Inc. (the "Company"). In addition, FINRA has approved a two thousand for one (2000:1) reverse stock split of the Company's common shares. The name change and reverse split will be effective January 4th, 2012. Effective with the reverse split the Company will have 3,416,243 common shares issued and outstanding.

The Company's transfer agent, Interwest Transfer Company, will process the corporate action. Furthermore, following the split a "D" will be placed on the ticker symbol for 20 business days. After 20 business days, the symbol will revert back to its original symbol. The Company's ticker symbol will remain "MTIZ" following the name change and reverse split.

Aclor International, Inc. (formerly Metiscan, Inc.) is a public holding company traded on the Pink Sheets under the symbol MTIZ. Its sole, wholly-owned subsidiary Aclor, Inc. is an international manufacturer and supplier of private label paper products. Aclor's customers include some of the most recognized and reputable office supply mass retailers worldwide and also include the largest consumer and office retailer in the United States. Aclor produces composition notebooks, spiral notebooks, wireless notebooks, and filler paper in its factory located in Nuevo Laredo, Tamaulipas, Mexico.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.


Contact Information

Investor Relations Contact:
StockOrange
Dylan Yarter
President
Voice: +1 (214) 872-6570
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->